Novel MR imaging contrast agents for cancer detection

BACKGROUND: Novel potential MR imaging contrast agents Gd-tetra-carboranylmethoxyphenyl-porphyrin (Gd-TCP), Gd-hematoporphyrin (Gd-H), Gd-DTPA-9.2.27 against melanoma, Gd-DTPA-WM53 against leukemia and Gd-DTPA-C595 against breast cancer cells were synthesized and applied to mice with different human...

Descripción completa

Detalles Bibliográficos
Autor principal: Shahbazi-Gahrouei, Daryoush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129053/
https://www.ncbi.nlm.nih.gov/pubmed/21772875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129053/
https://www.ncbi.nlm.nih.gov/pubmed/21772875

Ejemplares similares